DOT1L and breast carcinoma: Thus, DOT1L has beenconsidered as a potentially important therapeutic target for leukaemia9.A very recent study also shows that pharmacologic inhibition of H3K79 methylationsuppresses self-renewal of breast cancer stem cell (CSC), breast cancer proliferation,migration and invasion10, suggesting DOT1L to be a potential therapeutictarget for breast cancer.